Hospital-acquired Disease Testing Market: Enhancing Patient Safety Through Early Detection
The Hospital-acquired Disease Testing Market is playing a pivotal role in improving patient safety by enabling early detection and prevention of infections that occur within healthcare settings. Hospital-acquired infections (HAIs) such as pneumonia, bloodstream infections, urinary tract infections, and surgical site infections pose serious risks to patients and increase hospital costs and mortality rates. Growing awareness about infection control and advancements in diagnostic technologies have significantly driven the adoption of hospital-based disease testing across the world.
The demand for rapid and accurate diagnostic tools has surged, particularly after the COVID-19 pandemic, which emphasized the need for efficient infection surveillance and control. Advanced molecular diagnostic techniques, such as polymerase chain reaction (PCR), immunoassays, and next-generation sequencing (NGS), are widely used for detecting pathogens responsible for hospital-acquired diseases. These technologies allow healthcare professionals to identify infections quickly and implement timely treatment plans,…
